LGT Group Foundation
EndowmentPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1911278
VADUZ, N2
Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,872,174
+$157,462 QoQ
Shares Held
3,769
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#690
of 1,735 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LGT Group Foundation holds $1,872,174 across 1 Biotechnology name. VRTX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,769 | $1,872,174 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,872,174 | 3,769 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $1,714,712 | 3,840 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $2,050,092 | 4,522 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $1,809,375 | 4,620 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,219,401 | 2,739 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $1,642,569 | 3,388 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $939,900 | 2,334 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $1,025,500 | 2,205 | Shares | Defined | 2024-11-13 | |
| 2023-09-30 | $433,284 | 1,246 | Shares | Defined | 2023-11-06 | |
| No filing history on record for this holder in this stock. | ||||||